|
Re: Results from five new studies on Genomic Health's Oncotype DX breast cancer test
Rich,
A lot of docs that use it will not use it for Her2+ patients, because all of the results come back as high risk. I'm not sure it would have provided you any additional information to the pathology.
Hopeful
|